BioSig Technologies Inc. Announces Merger with Streamex Exchange Corp.

In a groundbreaking move set to reshape the landscape of real-world asset tokenization, BioSig Technologies Inc., a prominent player in the medical technology sector, has entered into a Letter of Intent (LOI) to merge with Streamex Exchange Corp. This all-stock transaction aims to create a publicly listed real-world asset tokenization company, poised to debut on the Nasdaq.

A Strategic Union

BioSig Technologies, known for its innovative signal processing solutions in cardiac catheter ablations, is merging with Streamex, a company specializing in real-world asset tokenization within the commodities space. This merger is designed to leverage BioSig’s expertise in health care technology and Streamex’s advanced infrastructure for on-chain commodity markets.

Innovative Technology Stack

The proposed merger highlights a robust technology stack, featuring a fully developed and operational primary issuance and decentralized exchange infrastructure. This setup is tailored for on-chain commodity markets, offering a commodity-focused real-world asset tokenization infrastructure and financing platform. The integration of these technologies aims to streamline the investment process, enhance capital availability for companies, and provide investors with new opportunities.

Access and Diversification

One of the key benefits of this merger is the ability for investors to gain access to real-world assets with the ease and security of cryptocurrency. This development allows for portfolio diversification with tangible investments in a digital-first world, bridging the gap between traditional asset classes and digital finance.

Leadership and Vision

The merger is led by seasoned industry executives, bringing together a wealth of experience and vision. This leadership is expected to drive the newly formed entity towards becoming a leader in the real-world asset tokenization space.

Market Implications

As BioSig Technologies Inc. navigates this transformative phase, the company’s stock, which recently closed at $1.37, reflects a significant journey from its 52-week low of $0.201 to a high of $2.57. With a market capitalization of $32,940,000, the merger presents a strategic opportunity to enhance BioSig’s market position and expand its technological footprint.

This merger marks a pivotal moment for both BioSig Technologies and Streamex Exchange Corp., setting the stage for innovation and growth in the intersection of health care technology and digital asset management.